Agile Therapeutics: Clinical Trials

9 completed. 4 Phase 1, 3 Phase 3, 2 Phase 2, 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4
Phase 3	3	Completed 3
Phase 2	2	Completed 2
Phase 4	1	Completed 1

Follow Agile Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System Twirla® (Levonorgestrel/Ethinyl Estradiol) Transdermal System - Residual Drug Amount of EE and LNG	Phase 4	Completed	Insud Pharma	28	2021-10-25	2026-08-27
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System AG200-15 - Healthy	Phase 3	Completed	Agile Therapeutics	2032	2014-08-01	2020-05-06
Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches levonorgestrel - Healthy	Phase 1 / Phase 2	Completed	Agile Therapeutics	36	2012-07-01	2018-01-23
Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers AG200-15 - Healthy	Phase 1	Completed	Agile Therapeutics	24	2011-05-01	2018-07-31
Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females AG200-15 - Healthy	Phase 1	Completed	Agile Therapeutics	24	2011-02-01	2018-12-31
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm AG200-15, Levora - Contraception	Phase 3	Completed	Agile Therapeutics	407	2010-10-01	2017-09-15
Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System AG200-15 (cycles 1-13), Lessina crossover to AG200-15 - Contraception	Phase 3	Completed	Agile Therapeutics	1504	2010-08-01	2018-07-03
AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol Ortho-Cyclen, AG200-15 - Healthy	Phase 1	Completed	Agile Therapeutics	36	2009-08-01	2018-01-23
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control levonorgestrel and ethinyl estradiol - Ovulation Suppression	Phase 2	Completed	Agile Therapeutics	123	2007-09-01	2018-07-05

Interventions

Transdermal Patch (4)  ·  Ethinyl Estradiol-Norgestrel Combination (2)  ·  Levonorgestrel (2)  ·  Administration, Cutaneous (1)  ·  Contraception (1)  ·  Contraceptives, Oral (1)  ·  Contraceptives, Oral, Hormonal (1)  ·  Ethinyl Estradiol (1)  ·  Hormonal Contraception (1)  ·  Moxifloxacin (1)  ·  ethinyl estradiol, levonorgestrel drug combination (1)

Countries

United States (7)

Top investigators

Elizabeth Garner, MD, MPH (5)  ·  Elizabeth Garner, MD (1)  ·  Elizabeth Garner, MD, PHD (1)  ·  Marie Foegh, MD (1)

Results publications

PMID 22133660, PMID 24402597, PMID 25582984, PMID 25586864, PMID 33259782